Gland Pharma Limited Working Capital to Net Assets Ratio
Gland Pharma Limited working capital to net assets ratio. Gland Pharma Limited (GLAND) has a Working Capital to Net Assets ratio of 57.1% as of March 2026. Working capital of Rs59.18 Billion (current assets of Rs75.27 Billion minus current liabilities of Rs16.08 Billion) is measured against net assets of Rs103.58 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Gland Pharma Limited (GLAND) tangible equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Gland Pharma Limited (2017–2026)
Working capital to net assets ratio of Gland Pharma Limited from 2017 to 2026. This chart shows how Gland Pharma Limited's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2017 to 2026. As of March 2026, the ratio stands at 57.1%, reflecting working capital of Rs59.18 Billion against net assets of Rs103.58 Billion INR. See operational self-sufficiency of Gland Pharma Limited to measure how many days the company can operate on defensive assets alone.
Gland Pharma Limited Working Capital to Net Assets Ratio by Year (2017–2026)
Gland Pharma Limited working capital to net assets ratio by year from 2017 to 2026. The table below presents the year-by-year Working Capital to Net Assets ratio for Gland Pharma Limited from 2017 to 2026, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see balance sheet size of Gland Pharma Limited.
| Year | WC/NA Ratio | Working Capital (INR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2026 | 57.1% | Rs59.18 Billion | Rs103.58 Billion | Rs75.27 Billion | Rs16.08 Billion | ▲ +0.1 pp |
| 2025 | 57.0% | Rs52.18 Billion | Rs91.51 Billion | Rs67.83 Billion | Rs15.65 Billion | ▲ +8.3 pp |
| 2024 | 48.7% | Rs42.47 Billion | Rs87.24 Billion | Rs56.45 Billion | Rs13.98 Billion | ▼ -28.9 pp |
| 2023 | 77.5% | Rs61.72 Billion | Rs79.59 Billion | Rs69.01 Billion | Rs7.29 Billion | ▲ +3.9 pp |
| 2022 | 73.6% | Rs52.70 Billion | Rs71.58 Billion | Rs58.52 Billion | Rs5.82 Billion | ▼ -4.5 pp |
| 2021 | 78.1% | Rs46.11 Billion | Rs59.03 Billion | Rs51.24 Billion | Rs5.13 Billion | ▲ +9.9 pp |
| 2020 | 68.2% | Rs24.87 Billion | Rs36.46 Billion | Rs28.46 Billion | Rs3.59 Billion | ▲ +4.5 pp |
| 2019 | 63.8% | Rs18.25 Billion | Rs28.62 Billion | Rs23.57 Billion | Rs5.33 Billion | ▲ +7.6 pp |
| 2018 | 56.1% | Rs13.53 Billion | Rs24.10 Billion | Rs17.32 Billion | Rs3.79 Billion | ▲ +0.9 pp |
| 2017 | 55.3% | Rs11.55 Billion | Rs20.90 Billion | Rs14.08 Billion | Rs2.53 Billion | — |